Margret Leosdottir on Statin–Ezetimibe Algorithm Dramatically Improving Post-MI LDL-C Outcomes
Margret Leosdottir, Senior cardiology consultant at Skane University Hospital, shared on LinkedIn:
”At Skåne University Hospital in Malmö, in November 2022 we launched an algorithm to support our CCU doctors to prescribe lipid-lowering therapy during ACS hospitalization, focused on increasing the use of ezetimibe for patients not expected to reach goal on high-dose atorvastatin alone.
The algorithm was inspired by prior work from France under the lead of Prof François Schiele.
In just a couple of months, at our hospital the proportion of patients reaching LDL-C goal at 2-months post-MI increased from 30% to 55%.
This increase has remained since, with approximately 65% of our patients now at goal at one-year post-MI
Today we launch a new version of the algorithm, switching primary choice of high-intensity statin to rosuvastatin and further adapting recommendations to the 2025 European Society of Cardiology and European Atherosclerosis Society Lipid GL update.
Failure to implement evidence-based medicine is a major cause of concern in today´s healthcare.
Often simple measures like these can carry us a long way, improving prognosis for our patients and making better use of limited healthcare resources.
The example also shows the usefulness of national registries like SWEDEHEART to track progress and benchmark quality improvement efforts at your clinic
With Emil Hagström and Jessica Schubert.”

Stay updated with Hemostasis Today.
-
Sep 11, 2026, 13:21Emmanuel J Favaloro: Rethinking Quality Control in VWD Testing
-
Sep 11, 2026, 13:10Tessa Youngner: New Free E-Course Introduces Comprehensive SCD Care
-
Sep 11, 2026, 12:55Identifying Key Research Priorities for VTE and Stroke – International Journal of Stroke
-
Sep 11, 2026, 12:43Helping Hematology Employers Reach Qualified Job Seekers – ASH
-
Sep 11, 2026, 12:22The First New Treatment for Essential Thrombocythemia in Nearly 30 Years
-
Sep 11, 2026, 12:20When Thrombosis Affects the Kidneys – World Thrombosis Day
-
Sep 11, 2026, 11:24Haroun Gajraj: Polidocanol or STS – Choosing the Right Sclerosant
-
Sep 11, 2026, 10:53A Patient-Centred Approach to Haemophilia B Care – EAHAD
-
Sep 11, 2026, 09:51Alfredo Lozada: Pelacarsen Lowers Lp(a), But Does It Lower CV Risk?